|
June 2018
Laborers’ Metropolitan Detroit Health Care Fund group will participate in medical drug prior authorization program
Beginning Aug. 1, 2018, Laborers’ Metropolitan Detroit Health Care Fund will participate in the medical drug prior authorization program.
You can find information about the medical drug prior authorization program by logging into web-DENIS, clicking on BCBSM Provider Publications and Resources, and selecting Newsletters and Resources. The information is located under Forms in a section titled Physician administered medications.
Keep in mind that the prior authorization requirement doesn’t apply to Federal Employee Program® members.
The list below reflects all the medications that are part of the medical drug prior authorization program.
Drugs in the medical drug prior authorization program |
Actemra® |
Elaprase® |
Kalbitor® |
Remicade® |
Acthar® gel |
Elelyso™ |
Kanuma™ |
Ruconest® |
Adagen® |
Entyvio™ |
Krystexxa® |
Signifor® LAR |
Aldurazyme® |
Exondys 51™ |
Lemtrada™ |
Simponi Aria® |
Aralast NP™ |
Fabrazyme® |
Lumizyme® |
Soliris® |
Aveed® |
Fasenra™ |
Luxturna™ |
Spinraza™ |
Benlysta® |
Firazyr® |
Makena® |
Stelara® |
Berinert® |
Flebogamma® DIF |
Mepsevii™ |
Stelara IV® |
Bivigam™ |
Gammagard Liquid® |
Myobloc® |
Synagis® |
Botox® |
Gammagard® S/D |
Myozyme® |
Testopel® |
Brineura™ |
Gammaked® |
Naglazyme® |
Tysabri® |
Carimune® NF |
Gammaplex® |
Nplate® |
Vimizim™ |
Cerezyme® |
Gamunex® |
Nucala® |
Vpriv® |
Cimzia® |
Glassia™ |
Ocrevus™ |
Xeomin® |
Cinqair® |
Hizentra® |
Octagam® |
Xgeva® |
Cinryze® |
HyQvia® |
Orencia® |
Xiaflex® |
Cosentyx™ |
Ilaris® |
Privigen® |
Xolair® |
Crysvita® |
Ilumya™ |
Prolastin®-C |
Yescarta® |
Cuvitru® |
Immune globulin |
Prolia® |
Zemaira® |
Dysport® |
Inflectra™ |
Radicava™ |
Zinplava™ |
| 
